Manila, Philippines – The 1 Million doses of Sinovac COVID-19 vaccines procured by the Philippine government arrived in the country on Thursday, June 10, 2021. These vaccines were developed by the Chinese drug-maker Sinovac Biotech.
The said shipment landed at Ninoy Aquino International Airport (NAIA) Terminal 2 on Thursday around 7:25 am.
Also present in receiving of the package is Vaccine czar and National Task Force against coronavirus disease 2019 Chief implementer Carlito Galvez Jr.


Chief implementer Carlito Galvez Jr. earlier said the government expects 1.5 million doses of Sinovac Covid-19 vaccines to be delivered on June 17, 2021.
According to Galvez, the 2.2M Pfizer vaccines that is expected to be delivered between June 10 to 11 has finally arrived around 9 in Thursday evening.
In a survey conducted by the Social Weather Station (SWS), the most preferred vaccines of Filipinos are from Sinovac and Pfizer-BioNTech.
The country has received a total of 7.5 million doses of SinoVac COVID-19 vaccines from which 1 million doses were donated by the Chinese government.
Covid-19 Vaccines Update
So far, the government has received a total of 12,608,210 Covid-19 doses of vaccines as of June 10, 2021.
Here is the table showing the number of vaccines delivered in the country from February 2021 to present.
Date | Name of Vaccines | Figure |
---|---|---|
Feb 28, 2021 | SinoVac | 600,000 |
March 24, 2021 | SinoVac | 400,000 |
March 29, 2021 | SinoVac | 1,000,000 |
April 11, 2021 | SinoVac | 500,000 |
April 19, 2021 | AstraZeneca | 525,600 |
April 22, 2021 | SinoVac | 500,000 |
April 29, 2021 | SinoVac | 500,000 |
May 1, 2021 | Gamaleya | 30,000 |
May 7, 2021 | SinoVac | 1,500,000 |
May 8, 2021 | AstraZeneca | 2,000,000 |
May 10, 2021 | Pfizer-BioNTech | 193,050 |
May 19, 2021 | SinoVac | 500,000 |
May 30, 2021 | Sputnik V | 50,000 |
June 6, 2021 | Sinovac | 1,000,000 |
June 10, 2021 | Sinovac | 1,000,000 |
June 10, 2021 | Pfizer-BioNTech | 2,279,160 |
The Philippine government has distributed 8,684,060 doses of COVID vaccines as of June 07, 2021. Each person need 2 doses of COVID-19 vaccine.
Since the vaccination rolled out by March 1, 1,681,722 were fully vaccinated and 4,632,826 received their first dose of vaccine. As of June 8, 2021, the Philippine government has administered a total of 6,314,548 doses of vaccines.
The government also assures that the vaccines is free for all its people.
The government is also expecting to receive AstraZeneca vaccines from World Health Organization (WHO) and from Pfizer-BioNTech within this year.
The target numbers of full vaccination by the end of the year are at least 58 million individuals.
DOH: Vaccination Priorities
The government approved the vaccination for economic frontline workers in essential sectors (A4) and indigent Filipinos (A5) beginning of June. So far, only health workers, senior citizens and persons with comorbidities have undergone the vaccination program. Here are the following categories in vaccination program.
Category | Priority group |
---|---|
A1 | Frontline health workers both national and local; public and non-public; health professional and non-professional (students, nursing aides, janitors, barangay health workers, et. al) |
A2 | Senior citizens (60-years old and above) |
A3 | Persons with comorbidities |
A4 | Economic frontline workers in essential sectors including uniformed personnel. |
A5 | Indigent Filipinos |
B1 | Teachers and Social workers |
B2 | Other Government Workers |
B3 | Other Essential Workers such as grocery store workers, bank workers, retail workers, mall workers |
B4 | Socio-demographic groups at significantly higher risk other than senior citizens and indigenous Filipinos such as persons deprived of liberty, persons with disabilities, Filipinos living in high-density areas, students |
B5 | Overseas FIlipino Workers |
B6 | Other remaining workforce |
C | Rest of the Filipino population not otherwise included in the above priority groups |
Efficacy Rates of SinoVac Vaccine
Based on the evaluation of SinoVac vaccines by the Philippine Food and Drug Administration (FDA), the efficacy rates are from 65.3% to 91.2% to aged 18-59 healthy individuals. 50.4% efficacy to those exposed in Covid-19 and 51% to 52% efficacy rates on senior citizens (60 above).
Your Reactions
Do you have clarifications/ comments about this article? Please feel free to drop one below.